Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1138817

	registered interest
	date	15/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Technology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many patient organisations are involved in the National Institute for Health and Care Excellence’s review of health technology assessment methods and processes.
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	uin	277170
	answer	answer is ministerial correction date of answer 23/07/2019 answer text <p>There are three patient/lay representatives on the methods working group with a wide range of experience, covering a range of topic areas, reflecting the programmes under review. Two of the patient/lay representatives also belong to the Patients Involved in NICE coalition.</p><p>Patient groups will be involved in the review of each of the specific methodological areas as detailed in the paper presented to the NICE board on 17 July 2019. Experts in the area will be invited to participate in topic specific methods task and finish groups.</p><p>NICE has established a dedicated patient working group. There are six patient organisation representatives on the group, including those who belong to the Patients Involved in NICE coalition. The group will work directly with patient/carer groups to coordinate the patient perspective on both methods and process. A stakeholder workshop with patient groups was held in January 2019 that included representatives from 22 patient organisations.</p><p>The patient working group has recently disseminated a survey to patient umbrella groups to develop a clear understanding of the patient perspective on both methods and processes. The survey runs until 5pm on Monday 12 August 2019. It will be promoted via social media and sent directly to groups working with NICE. Patient organisations can communicate with representatives on the methods working group and patient working group outside of this survey.</p><p>Patient organisations will have the opportunity to comment directly on proposals during the public consultation in summer 2020.</p><p>NICE is implementing other opportunities to encourage more patient group involvement throughout the review via provision of a subscription based bulletin for updates and information (which people can subscribe to via their website) and exploring arrangements of additional engagement sessions (i.e. webinars), as and when appropriate.</p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 277171 277172 question first answered 23/07/2019 16:34:14 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4056 label Biography information for Nic Dakin

1138818

	registered interest
	date	15/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Technology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what opportunities patient organisations will have to make representations to the National Institute for Health and Care Excellence’s review of health technology assessment methods and processes.
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	uin	277171
	answer	answer is ministerial correction date of answer 23/07/2019 answer text <p>There are three patient/lay representatives on the methods working group with a wide range of experience, covering a range of topic areas, reflecting the programmes under review. Two of the patient/lay representatives also belong to the Patients Involved in NICE coalition.</p><p>Patient groups will be involved in the review of each of the specific methodological areas as detailed in the paper presented to the NICE board on 17 July 2019. Experts in the area will be invited to participate in topic specific methods task and finish groups.</p><p>NICE has established a dedicated patient working group. There are six patient organisation representatives on the group, including those who belong to the Patients Involved in NICE coalition. The group will work directly with patient/carer groups to coordinate the patient perspective on both methods and process. A stakeholder workshop with patient groups was held in January 2019 that included representatives from 22 patient organisations.</p><p>The patient working group has recently disseminated a survey to patient umbrella groups to develop a clear understanding of the patient perspective on both methods and processes. The survey runs until 5pm on Monday 12 August 2019. It will be promoted via social media and sent directly to groups working with NICE. Patient organisations can communicate with representatives on the methods working group and patient working group outside of this survey.</p><p>Patient organisations will have the opportunity to comment directly on proposals during the public consultation in summer 2020.</p><p>NICE is implementing other opportunities to encourage more patient group involvement throughout the review via provision of a subscription based bulletin for updates and information (which people can subscribe to via their website) and exploring arrangements of additional engagement sessions (i.e. webinars), as and when appropriate.</p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 277170 277172 question first answered 23/07/2019 16:34:14 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4056 label Biography information for Nic Dakin

1138819

	registered interest
	date	15/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Technology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he will take to ensure the broadest number of patient groups can participate in the National Institute for Health and Care Excellence’s review of health technology assessment methods and processes.
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	uin	277172
	answer	answer is ministerial correction date of answer 23/07/2019 answer text <p>There are three patient/lay representatives on the methods working group with a wide range of experience, covering a range of topic areas, reflecting the programmes under review. Two of the patient/lay representatives also belong to the Patients Involved in NICE coalition.</p><p>Patient groups will be involved in the review of each of the specific methodological areas as detailed in the paper presented to the NICE board on 17 July 2019. Experts in the area will be invited to participate in topic specific methods task and finish groups.</p><p>NICE has established a dedicated patient working group. There are six patient organisation representatives on the group, including those who belong to the Patients Involved in NICE coalition. The group will work directly with patient/carer groups to coordinate the patient perspective on both methods and process. A stakeholder workshop with patient groups was held in January 2019 that included representatives from 22 patient organisations.</p><p>The patient working group has recently disseminated a survey to patient umbrella groups to develop a clear understanding of the patient perspective on both methods and processes. The survey runs until 5pm on Monday 12 August 2019. It will be promoted via social media and sent directly to groups working with NICE. Patient organisations can communicate with representatives on the methods working group and patient working group outside of this survey.</p><p>Patient organisations will have the opportunity to comment directly on proposals during the public consultation in summer 2020.</p><p>NICE is implementing other opportunities to encourage more patient group involvement throughout the review via provision of a subscription based bulletin for updates and information (which people can subscribe to via their website) and exploring arrangements of additional engagement sessions (i.e. webinars), as and when appropriate.</p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 277170 277171 question first answered 23/07/2019 16:34:14 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4056 label Biography information for Nic Dakin

1138859

	registered interest
	date	15/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Genetics: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Clinical Advisory Group for Genomics, if he will set out (a) its terms of reference, (b) when it will first meet, (c) how patient voice will be incorporated into its work, (d) who it will report to and (e) when the (i) Commissioning Policy for Preimplantation Genetic Diagnosis review and (ii) other work of its predecessor, the Clinical Reference Group for Medical Genetics, will be completed; and if he will make a statement.
	tabling member constituency	Hornsey and Wood Green
	tabling member printed	Catherine West
	uin	277243
	answer	answer is ministerial correction date of answer 23/07/2019 answer text <p>NHS England has paused the recruitment for the clinical genetics clinical reference group to ensure the right advisory groups are in place to provide clinical advice across the breadth and depth of the future NHS Genomic Medicine Service.</p><p>These new arrangements will need consider clinical genetics and genetic counselling, but also wider implications of genomics for the National Health Service. Any future arrangements will have appropriate representation, including patient and public voices.</p><p>NHS England is progressing the clinical commissioning policy for Preimplantation Genetic Diagnosis (PGD). This work will include assessment of the treatment pathways for existing PGD services and consideration of the ethical issues. NHS England will continue to seek input from clinicians and patients throughout this work.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 23/07/2019 16:06:02 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4523 label Biography information for Catherine West

1138879

	registered interest
	date	15/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Audiology and Hearing Aids
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer on 12 June 2019 to Question 260081, whether his Department will require Clinical Commissioning Groups to collect and publish data in a comparable form on (a) the amount spent on audiology services, (b) the number of hearing aids fitted and (c) outcomes of hearing aid fittings.
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	uin	277193
	answer	answer is ministerial correction date of answer 23/07/2019 answer text <p>Clinical commissioning groups (CCGs) are responsible for the collection and collation of audiology data to enable them to manage regional needs. NHS England has no plans to mandate CCGs to collect or publish their data in a comparable form.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 23/07/2019 16:03:42 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4126 label Biography information for Mary Glindon

1138902

	registered interest
	date	15/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Cornwall
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many (a) doctors and (b) nurses are employed on a full-time basis for cancer care in Cornwall.
	tabling member constituency	North Cornwall
	tabling member printed	Scott Mann
	uin	277228
	answer	answer is ministerial correction date of answer 23/07/2019 answer text <p>NHS Digital publishes hospital and community health services workforce statistics for National Health Service trusts and clinical commissioning groups in England. However, the information held by NHS Digital does not capture sufficient level of detail to identify those working in cancer care in Cornwall.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 23/07/2019 16:35:45 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4496 label Biography information for Scott Mann

1138923

	registered interest
	date	15/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Diagnosis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to his oral statement of 1 July 2019, Official Report, column 929, on the NHS Long Term Plan: Implementation, what steps his Department is taking to achieve the target to diagnose 75 per cent of cancers at stage 1 and 2 for less survivable cancers.
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	uin	277173
	answer	answer is ministerial correction date of answer 23/07/2019 answer text <p>To achieve the NHS Long Term Plan ambition, we are modernising our world-renowned cancer screening programmes by introducing faecal immunochemical testing into the NHS Bowel Cancer Screening Programme and human papillomavirus as the primary test in the NHS Cervical Screening Programme.</p><p>NHS England is establishing rapid diagnostic centres, which build on the 10 models piloted through the ‘Accelerate, Coordinate and Evaluate’ programme, which have focussed on diagnosing cancers where patients often present with non-specific symptoms and may go to their general practitioner (GP) many times before being sent for appropriate tests. These will be particularly important for the less-survivable cancers.</p><p>NHS England is extending lung health checks, targeting clinical commissioning groups with the lowest survival rates. In Greater Manchester introducing low dose CT health checks saw an almost five-fold reduction in stage 4 disease, with 80% of cancers diagnosed at an early stage.</p><p>There will also be efforts to continue to raise awareness cancer symptoms, lower the threshold for GP referrals and accelerate access to diagnosis and treatment.</p><p>As set out in the NHS Long Term Plan Implementation Framework, local systems are being asked to create their five-year strategic plans to deliver the commitments in the NHS Long Term Plan. Plans should be created by November 2019. System plans will then be aggregated, brought together with additional national activity and published as part of a national implementation plan by the end of 2019. These plans will include the less survivable cancers.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 277174 question first answered 23/07/2019 16:37:26 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4056 label Biography information for Nic Dakin

1138924

	registered interest
	date	15/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Diagnosis
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to his oral statement of 1 July 2019, Official Report, column 929, on the NHS Long Term Plan: Implementation, if he will publish his plans to achieve the target to diagnose 75 per cent of cancers at stage 1 and 2 for less survivable cancers.
	tabling member constituency	Scunthorpe
	tabling member printed	Nic Dakin
	uin	277174
	answer	answer is ministerial correction date of answer 23/07/2019 answer text <p>To achieve the NHS Long Term Plan ambition, we are modernising our world-renowned cancer screening programmes by introducing faecal immunochemical testing into the NHS Bowel Cancer Screening Programme and human papillomavirus as the primary test in the NHS Cervical Screening Programme.</p><p>NHS England is establishing rapid diagnostic centres, which build on the 10 models piloted through the ‘Accelerate, Coordinate and Evaluate’ programme, which have focussed on diagnosing cancers where patients often present with non-specific symptoms and may go to their general practitioner (GP) many times before being sent for appropriate tests. These will be particularly important for the less-survivable cancers.</p><p>NHS England is extending lung health checks, targeting clinical commissioning groups with the lowest survival rates. In Greater Manchester introducing low dose CT health checks saw an almost five-fold reduction in stage 4 disease, with 80% of cancers diagnosed at an early stage.</p><p>There will also be efforts to continue to raise awareness cancer symptoms, lower the threshold for GP referrals and accelerate access to diagnosis and treatment.</p><p>As set out in the NHS Long Term Plan Implementation Framework, local systems are being asked to create their five-year strategic plans to deliver the commitments in the NHS Long Term Plan. Plans should be created by November 2019. System plans will then be aggregated, brought together with additional national activity and published as part of a national implementation plan by the end of 2019. These plans will include the less survivable cancers.</p> answering member constituency South Ribble answering member printed Seema Kennedy grouped question UIN 277173 question first answered 23/07/2019 16:37:26 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4056 label Biography information for Nic Dakin